Medical Devices

With a unique single-use design and remote operation, Microbot Medical's LIBERTY system promises to make robotic surgery more accessible and safer.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

With major grants from top foundations, Lario Therapeutics expands its precision neuroscience platform, offering new hope for complex neurological disorders.

As argenx prepares its full-year 2025 update, investors are watching if the VYVGART sales boom can fund a pipeline aimed at dominating autoimmune care.

With its CEO and CFO set for key conferences, Aptar will address investors following a strong sales quarter but facing questions on profitability.

With major investor conferences ahead, Ceribell showcases impressive revenue growth fueled by its AI-driven EEG system and a string of new FDA clearances.

A landmark deal with Abu Dhabi's SSMC will make the UAE a regional hub for Nyxoah's innovative Genio implant, targeting a major health issue.

The NYSE-listed medtech firm will detail its "ecosystem" strategy for the booming shoulder surgery market amid rapid revenue growth and a push for profitability.

With COVID revenue fading, QuidelOrtho will use a key conference to prove its diversified diagnostics model can deliver on growth, margins, and cash flow.

The Nashville-based clinic brings its luxury, results-driven skincare model to Arlington, VA, tapping into national wellness trends and rapid growth.

Johnson & Johnson is investing over $1 billion in a new Pennsylvania cell therapy hub, promising revolutionary treatments and thousands of new jobs.

Flatiron Health launches a first-of-its-kind AI platform, merging data from 400,000 patients to revolutionize prostate cancer research and treatment.

The latest astronaut crew on the ISS is conducting cutting-edge research in microgravity, aiming to revolutionize healthcare and environmental tech on Earth.

New head-to-head study results for POSLUMA PET imaging could redefine diagnostic clarity for prostate cancer, promising earlier and more precise detection.

After two decades of global use, Fziomed's anti-adhesion gel has treated one million patients, signaling a major shift in post-surgical recovery.

The prestigious medical center's adoption of the XTRAC laser signals a major shift in treating chronic skin disease and expands hope for millions of patients.

New data on Spyre Therapeutics' SPY003 suggests a twice-yearly shot for IBD is possible, part of a broader strategy to challenge market giants.

The NYC-based private equity firm's oversubscribed Fund IX far exceeds its predecessor, showing robust investor confidence in its long-term strategy.

Bausch + Lomb beats Q4 revenue forecasts, propelled by its blockbuster dry eye drug MIEBO, and issues a confident financial outlook for 2026.

AcuityMD's new Salesforce integration promises to eliminate data silos and boost sales for MedTech firms, marking a strategic leap for the AI unicorn.